Oppenheimer
Upgrade grade
A
Downgrade grade
B
Oppenheimer & Co. was founded in 1881 as a private banking partnership and has evolved into a full-service investment bank headquartered in New York with significant research and trading operations. The firm employs thousands of professionals across its various divisions and maintains a substantial presence in equity research, with approximately 6,160 analyst ratings calls on US equities demonstrating the breadth of their coverage universe. Oppenheimer is particularly well-known for its deep expertise in technology, healthcare, financial services, and industrials, where their analysts have built strong track records of identifying inflection points and emerging growth opportunities. The firm has cultivated a distinctive culture of independent research, with a reputation for allowing their analysts to maintain contrarian positions when warranted by fundamentals, rather than herding toward consensus views that characterize much of the sell-side research industry.
Upgrades
428
78.97% win rate
· avg +3.19% D1
Downgrades
495
75.56% win rate
· avg -5.71% D1
Avg Gap — Upgrades
+2.67%
open vs prev close
Avg Gap — Downgrades
-5.53%
open vs prev close
Performance by Sector
| Sector | ↑ Win% | ↑ D1 | ↓ Win% | ↓ D1 |
|---|---|---|---|---|
| Technology | 78.64% (103) | +4.12% | 75.89% (112) | -6.15% |
| Healthcare | 84.81% (79) | +4.46% | 76.54% (81) | -11.74% |
| Consumer Cyclical | 81.25% (64) | +2.29% | 71.43% (84) | -3.03% |
| Industrials | 76.92% (52) | +2.40% | 86.15% (65) | -4.10% |
| Financial Services | 78.43% (51) | +2.16% | 63.16% (57) | -1.45% |
| Communication Services | 77.42% (31) | +2.78% | 83.87% (31) | -8.83% |
| Consumer Defensive | 56.25% (16) | +0.83% | 90.91% (22) | -5.70% |
| Energy | 63.64% (11) | +3.66% | 61.90% (21) | -4.36% |
| Real Estate | 90.91% (11) | +2.85% | 80.00% (15) | -1.76% |
Win Rate by Year
| Year | ↑ Win% | ↑ Calls | ↓ Win% | ↓ Calls |
|---|---|---|---|---|
| 2026 | 76.7% | 30 | 80.0% | 30 |
| 2025 | 84.4% | 32 | 64.0% | 25 |
| 2024 | 81.3% | 32 | 88.6% | 35 |
| 2023 | 72.7% | 22 | 78.9% | 57 |
| 2022 | 78.4% | 37 | 72.1% | 43 |
| 2021 | 73.7% | 38 | 83.8% | 37 |
| 2020 | 78.8% | 52 | 63.2% | 38 |
| 2019 | 82.6% | 23 | 74.4% | 43 |
| 2018 | 68.0% | 25 | 79.2% | 24 |
| 2017 | 81.0% | 21 | 66.7% | 21 |
Recent Calls
| Date | Ticker | Company | Sector | Action | Grade Change | PT | Gap | D1 |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | COCO | The Vita Coco Company, Inc. | Consumer Defensive | Initiates | Outperform | $70 | +1.5% | -0.4% |
| Sep 30, 2026 | UFPI | UFP Industries, Inc. | Basic Materials | Initiates | Perform | — | +0.1% | -2.0% |
| Sep 30, 2026 | SKY | Champion Homes, Inc. | Consumer Cyclical | Initiates | Perform | — | -1.0% | -1.1% |
| Sep 30, 2026 | CVCO | Cavco Industries, Inc. | Consumer Cyclical | Initiates | Outperform | $720 | +1.6% | +0.7% |
| Sep 30, 2026 | NICE | NICE Ltd. | Technology | Upgrade | Perform → Outperform | $150 | +3.0% | +4.2% |
| Sep 29, 2026 | FCEL | FuelCell Energy, Inc. | Industrials | Initiates | Outperform | $24 | +8.6% | +4.7% |
| Sep 24, 2026 | MCD | McDonald's Corporation | Consumer Cyclical | Reiterates | Outperform | $295 | +0.6% | -0.5% |
| Sep 24, 2026 | DT | Dynatrace, Inc. | Technology | Reiterates | Outperform | $71 | +0.6% | +0.3% |
| Sep 23, 2026 | INVA | Innoviva, Inc. | Healthcare | Reiterates | Outperform | $35 | +0.6% | -3.5% |
| Sep 23, 2026 | VTRS | Viatris Inc. | Healthcare | Initiates | Outperform | $25 | +0.5% | -0.3% |
| Sep 23, 2026 | VNDA | Vanda Pharmaceuticals Inc. | Healthcare | Initiates | Outperform | $10 | +2.1% | -3.3% |
| Sep 23, 2026 | TTC | The Toro Company | Industrials | Initiates | Outperform | $120 | +0.4% | +2.2% |
| Sep 23, 2026 | TEVA | Teva Pharmaceutical Industries Limited | Healthcare | Initiates | Outperform | $50 | +0.4% | -1.3% |
| Sep 23, 2026 | PCRX | Pacira BioSciences, Inc. | Healthcare | Initiates | Outperform | $32 | +1.2% | -0.3% |
| Sep 23, 2026 | CRMD | CorMedix Inc. | Healthcare | Initiates | Outperform | $15 | +3.2% | -1.2% |
| Sep 23, 2026 | COLL | Collegium Pharmaceutical, Inc. | Healthcare | Initiates | Outperform | $50 | +2.0% | -1.4% |
| Sep 23, 2026 | ANIP | ANI Pharmaceuticals, Inc. | Healthcare | Initiates | Perform | — | -1.2% | -4.5% |
| Sep 23, 2026 | AMRX | Amneal Pharmaceuticals, Inc. | Healthcare | Initiates | Outperform | $27 | +1.0% | -0.9% |
| Sep 22, 2026 | MSFT | Microsoft Corporation | Technology | Reiterates | Outperform | $570 | +1.1% | -0.7% |
| Sep 17, 2026 | KOPN | Kopin Corporation | Technology | Initiates | Outperform | $7 | +7.1% | +9.0% |
| Sep 15, 2026 | VSH | Vishay Intertechnology, Inc. | Technology | Initiates | Outperform | $42 | +2.1% | +2.0% |
| Sep 15, 2026 | ASTH | Astrana Health, Inc. | Healthcare | Initiates | Outperform | $53 | +0.3% | -3.2% |
| Sep 15, 2026 | ETSY | Etsy, Inc. | Consumer Cyclical | Upgrade | Perform → Outperform | $90 | +2.6% | -0.6% |
| Sep 10, 2026 | AEHR | Aehr Test Systems | Technology | Initiates | Outperform | $120 | -2.4% | -1.8% |
| Sep 9, 2026 | AKTS | Aktis Oncology, Inc. | Healthcare | Initiates | Outperform | $40 | +2.2% | -3.8% |